TrialThe Lancet. Haematology2019

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.

Brenda M Sandmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.